Literature DB >> 28605613

Hepatocellular Carcinoma: A Global Disease in Need of Individualized Treatment Strategies.

Nicola Personeni1, Lorenza Rimassa1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28605613     DOI： 10.1200/JOP.2017.024604

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  7 in total

1.  Rational Design, Synthesis, and Mechanism of (3S,4R)-3-Amino-4-(difluoromethyl)cyclopent-1-ene-1-carboxylic Acid: Employing a Second-Deprotonation Strategy for Selectivity of Human Ornithine Aminotransferase over GABA Aminotransferase.

Authors:  Wei Zhu; Arseniy Butrin; Rafael D Melani; Peter F Doubleday; Glaucio Monteiro Ferreira; Mauricio T Tavares; Thahani S Habeeb Mohammad; Brett A Beaupre; Neil L Kelleher; Graham R Moran; Dali Liu; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2022-03-16       Impact factor: 16.383

2.  A Remarkable Difference That One Fluorine Atom Confers on the Mechanisms of Inactivation of Human Ornithine Aminotransferase by Two Cyclohexene Analogues of γ-Aminobutyric Acid.

Authors:  Wei Zhu; Peter F Doubleday; Daniel S Catlin; Pathum M Weerawarna; Arseniy Butrin; Sida Shen; Zdzislaw Wawrzak; Neil L Kelleher; Dali Liu; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2020-03-01       Impact factor: 15.419

3.  The (Eternal) Debate on Microwave Ablation Versus Radiofrequency Ablation in BCLC-A Hepatocellular Carcinoma.

Authors:  Angela Dalia Ricci; Alessandro Rizzo; Chiara Bonucci; Simona Tavolari; Andrea Palloni; Giorgio Frega; Veronica Mollica; Nastassja Tober; Elena Mazzotta; Cristina Felicani; Carla Serra; Giovanni Brandi
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

4.  Remarkable and Unexpected Mechanism for (S)-3-Amino-4-(difluoromethylenyl)cyclohex-1-ene-1-carboxylic Acid as a Selective Inactivator of Human Ornithine Aminotransferase.

Authors:  Wei Zhu; Peter F Doubleday; Arseniy Butrin; Pathum M Weerawarna; Rafael D Melani; Daniel S Catlin; Timothy A Dwight; Dali Liu; Neil L Kelleher; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2021-05-20       Impact factor: 16.383

5.  Determination of the pH dependence, substrate specificity, and turnovers of alternative substrates for human ornithine aminotransferase.

Authors:  Arseniy Butrin; Anastassiya Butrin; Zdzislaw Wawrzak; Graham R Moran; Dali Liu
Journal:  J Biol Chem       Date:  2022-04-20       Impact factor: 5.486

6.  Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib.

Authors:  Haruki Uojima; Makoto Chuma; Yoshiaki Tanaka; Hisashi Hidaka; Takahide Nakazawa; Shogo Iwabuchi; Satoshi Kobayashi; Nobuhiro Hattori; Katsuaki Ogushi; Manabu Morimoto; Tatehiro Kagawa; Katsuaki Tanaka; Makoto Kako; Wasaburo Koizumi
Journal:  Liver Cancer       Date:  2019-12-06       Impact factor: 11.740

7.  Combination of psoas muscle mass index and neutrophil/lymphocyte ratio as a prognostic predictor for patients undergoing nonsurgical hepatocellular carcinoma therapy.

Authors:  Yusuke Sugama; Koji Miyanishi; Takahiro Osuga; Shingo Tanaka; Kota Hamaguchi; Ryo Ito; Hiroki Sakamoto; Tomohiro Kubo; Hiroyuki Ohnuma; Kazuyuki Murase; Kohich Takada; Masayoshi Kobune; Junji Kato
Journal:  JGH Open       Date:  2021-11-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.